Sulphonamides Market Report

Global and Region Sulphonamides Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：217
  • REPORT CODE：GMM974027
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Sulphonamides market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Sulphonamidesmarket, defines the market attractiveness level of Sulphonamides market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Sulphonamides industry, describes the types of Sulphonamides market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sulphonamides market and the development prospects and opportunities of Sulphonamides industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sulphonamides market in Chapter 13.

    By Player:

    • Novartis International AG

    • Mylan Pharmaceuticals

    • Par Pharmaceutical

    • Roche Holding AG

    • Sanofi Aventis

    • Bayer AG

    • King Pharmaceuticals

    • GlaxoSmithKline

    • Pfizer

    • Boehringer Ingelheim Pharmaceuticals

    • Stiefel Laboratories

    • Abbott Laboratories

    By Type:

    • Orally Absorbable Sulfonamide

    • Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

    • Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)

    By End-User:

    • Skin Infections

    • Gastro Intestinal Tract (GIT) Infection

    • Meningitis

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Sulphonamides Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Sulphonamides Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Sulphonamides Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Sulphonamides Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Sulphonamides Market Analysis and Outlook to 2022

    • 7.1 Global Sulphonamides Consumption (2017-2022)

    • 7.2 United States Sulphonamides Consumption (2017-2022)

    • 7.3 Europe Sulphonamides Consumption (2017-2022)

    • 7.4 China Sulphonamides Consumption (2017-2022)

    • 7.5 Japan Sulphonamides Consumption (2017-2022)

    • 7.6 India Sulphonamides Consumption (2017-2022)

    • 7.7 South Korea Sulphonamides Consumption (2017-2022)

    8 Region and Country-wise Sulphonamides Market Analysis and Outlook to 2028

    • 8.1 Global Sulphonamides Consumption Forecast (2022-2028)

    • 8.2 United States Sulphonamides Consumption Forecast (2022-2028)

    • 8.3 Europe Sulphonamides Consumption Forecast (2022-2028)

    • 8.4 China Sulphonamides Consumption Forecast (2022-2028)

    • 8.5 Japan Sulphonamides Consumption Forecast (2022-2028)

    • 8.6 India Sulphonamides Consumption Forecast (2022-2028)

    • 8.7 South Korea Sulphonamides Consumption Forecast (2022-2028)

    9 Global Sulphonamides Market Outlook by Types and Applications to 2022

    • 9.1 Global Sulphonamides Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Orally Absorbable Sulfonamide Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Sulphonamides Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Skin Infections Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Gastro Intestinal Tract (GIT) Infection Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Meningitis Consumption and Growth Rate (2017-2022)

    10 Global Sulphonamides Market Outlook by Types and Applications to 2028

    • 10.1 Global Sulphonamides Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Orally Absorbable Sulfonamide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Sulphonamides Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Skin Infections Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Gastro Intestinal Tract (GIT) Infection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Meningitis Consumption Forecast and Growth Rate (2022-2028)

    11 Global Sulphonamides Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Sulphonamides Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Sulphonamides Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Sulphonamides Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Sulphonamides Market Competitive Analysis

    • 14.1 Novartis International AG

      • 14.1.1 Novartis International AG Company Details

      • 14.1.2 Novartis International AG Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis International AG Sulphonamides Product and Service

    • 14.2 Mylan Pharmaceuticals

      • 14.2.1 Mylan Pharmaceuticals Company Details

      • 14.2.2 Mylan Pharmaceuticals Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Mylan Pharmaceuticals Sulphonamides Product and Service

    • 14.3 Par Pharmaceutical

      • 14.3.1 Par Pharmaceutical Company Details

      • 14.3.2 Par Pharmaceutical Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Par Pharmaceutical Sulphonamides Product and Service

    • 14.4 Roche Holding AG

      • 14.4.1 Roche Holding AG Company Details

      • 14.4.2 Roche Holding AG Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Roche Holding AG Sulphonamides Product and Service

    • 14.5 Sanofi Aventis

      • 14.5.1 Sanofi Aventis Company Details

      • 14.5.2 Sanofi Aventis Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Aventis Sulphonamides Product and Service

    • 14.6 Bayer AG

      • 14.6.1 Bayer AG Company Details

      • 14.6.2 Bayer AG Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bayer AG Sulphonamides Product and Service

    • 14.7 King Pharmaceuticals

      • 14.7.1 King Pharmaceuticals Company Details

      • 14.7.2 King Pharmaceuticals Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 King Pharmaceuticals Sulphonamides Product and Service

    • 14.8 GlaxoSmithKline

      • 14.8.1 GlaxoSmithKline Company Details

      • 14.8.2 GlaxoSmithKline Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 GlaxoSmithKline Sulphonamides Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Sulphonamides Product and Service

    • 14.10 Boehringer Ingelheim Pharmaceuticals

      • 14.10.1 Boehringer Ingelheim Pharmaceuticals Company Details

      • 14.10.2 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Product and Service

    • 14.11 Stiefel Laboratories

      • 14.11.1 Stiefel Laboratories Company Details

      • 14.11.2 Stiefel Laboratories Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Stiefel Laboratories Sulphonamides Product and Service

    • 14.12 Abbott Laboratories

      • 14.12.1 Abbott Laboratories Company Details

      • 14.12.2 Abbott Laboratories Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Abbott Laboratories Sulphonamides Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Sulphonamides

    • Figure Sulphonamides Picture

    • Table Global Sulphonamides Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sulphonamides Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sulphonamides Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Sulphonamides Consumption by Country (2017-2022)

    • Figure United States Sulphonamides Consumption and Growth Rate (2017-2022)

    • Table Europe Sulphonamides Consumption and Growth Rate (2017-2022)

    • Figure China Sulphonamides Consumption and Growth Rate (2017-2022)

    • Figure Japan Sulphonamides Consumption and Growth Rate (2017-2022)

    • Figure India Sulphonamides Consumption and Growth Rate (2017-2022)

    • Figure South Korea Sulphonamides Consumption and Growth Rate (2017-2022)

    • Figure Global Sulphonamides Consumption Forecast by Country (2022-2028)

    • Figure United States Sulphonamides Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Sulphonamides Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Sulphonamides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Sulphonamides Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Sulphonamides Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Sulphonamides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orally Absorbable Sulfonamide Consumption and Growth Rate (2017-2022)

    • Figure Global Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Consumption and Growth Rate (2017-2022)

    • Figure Global Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Consumption and Growth Rate (2017-2022)

    • Figure Global Skin Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Gastro Intestinal Tract (GIT) Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Meningitis Consumption and Growth Rate (2017-2022)

    • Figure Global Orally Absorbable Sulfonamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Skin Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastro Intestinal Tract (GIT) Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningitis Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Sulphonamides Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Sulphonamides Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis International AG (Foundation Year, Company Profile and etc.)

    • Table Novartis International AG Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG Sulphonamides Product and Service

    • Table Mylan Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Mylan Pharmaceuticals Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Pharmaceuticals Sulphonamides Product and Service

    • Table Par Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Par Pharmaceutical Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Par Pharmaceutical Sulphonamides Product and Service

    • Table Roche Holding AG (Foundation Year, Company Profile and etc.)

    • Table Roche Holding AG Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Holding AG Sulphonamides Product and Service

    • Table Sanofi Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi Aventis Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Aventis Sulphonamides Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Sulphonamides Product and Service

    • Table King Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table King Pharmaceuticals Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table King Pharmaceuticals Sulphonamides Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Sulphonamides Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Sulphonamides Product and Service

    • Table Boehringer Ingelheim Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Pharmaceuticals Sulphonamides Product and Service

    • Table Stiefel Laboratories (Foundation Year, Company Profile and etc.)

    • Table Stiefel Laboratories Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stiefel Laboratories Sulphonamides Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Sulphonamides Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Sulphonamides Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US